- Home
- PLRX vs NDMO Comparison
PLRX vs NDMO Comparison
Compare PLRX & NDMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PLRX | NDMO |
|---|---|---|
| Founded | 2015 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 79.9M | 604.7M |
| IPO Year | 2020 | 2019 |
Fundamental Metrics
Financial Performance| Metric | PLRX | NDMO |
|---|---|---|
| Price | $1.32 | $10.27 |
| Analyst Decision | Hold | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $2.67 | N/A |
| AVG Volume (30 Days) | ★ 533.4K | 107.0K |
| Earning Date | 03-11-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 29.97 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.09 | $9.30 |
| 52 Week High | $1.95 | $10.82 |
Technical Indicators
Market Signals| Indicator | PLRX | NDMO |
|---|---|---|
| Relative Strength Index (RSI) | 51.58 | 35.87 |
| Support Level | $1.12 | $9.94 |
| Resistance Level | $1.36 | $10.60 |
| Average True Range (ATR) | 0.07 | 0.14 |
| MACD | -0.00 | -0.03 |
| Stochastic Oscillator | 36.59 | 8.77 |
Price Performance
Historical ComparisonAbout PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.
About NDMO Nuveen Dynamic Municipal Opportunities Fund of Beneficial Interest
Nuveen Dynamic Municipal Opportunities is a closed-end management investment company. Its investment objective is to seek total return through income exempt from regular federal income taxes and capital appreciation. A majority of its investments are made in municipal securities, the income from which is exempted from regular federal income taxes.